ARLINGTON HEIGHTS, Ill., April 6, 2011 /PRNewswire/ —
MEDX, Inc., a leading provider of nuclear medicine equipment, today
introduced the next generation T-Quest™ compact gamma camera.
The FDA-cleared T-Quest, includes enhanced thyroid imaging
and now features expanded imaging capabilities to perform
parathyroid, sentinel node, MUGA, gastric emptying, hepatobiliary,
bone spots and other small organ studies. The Company also
announced the first installations for the powerful new T-Quest at
two leading acute care hospitals, Meritus Medical Center in
Hagerstown, MD and St. Barnabas Medical Center in Livingston,
NJ.
“We’re pleased to see immediate market reaction to the expanded
imaging capabilities of the powerful next generation T-Quest
camera,” said Sean McDermott, managing partner, MEDX, Inc.
“Offering high quality imaging capabilities for thyroid and
ancillary exams, the T-Quest enables sites to focus utilization of
their dual-head cameras on high revenue exams that require a large
field of view. This image quality and low lifetime system
cost, offers medium to large hospitals and imaging centers a
cost-effective tool to expand volume, improve efficiency and
provide quality patient care.”
Commercially available worldwide, the compact T-Quest provides
high-quality imaging capabilities and the freedom to perform long
duration time/activity studies. Its minimized focal distance and
mm/pixel ratio maximizes diagnostic quality through improved image
resolution. The results of this combination are increased
operating efficiency, better imaging economics and improved
diagnostic results. Requiring less than eight square feet of floor
space, T-Quest is the smart choice for facilities operating with
space and patient capacity limitations. The system features a 6
inch field of view and lightweight collimators which are easily
changed by hand. Its unobtrusive design promotes patient
comfort and is non-claustropho
‘/>”/>
